The Effect of Viloxazine Extended-Release Capsules on Functional Impairments Associated with Attention-Deficit/Hyperactivity Disorder (ADHD) in Children and Adolescents in Four Phase 3 Placebo-Controlled Trials
Azmi Nasser,1 Joseph T Hull,1 Tesfaye Liranso,2 Gregory D Busse,3 Zare Melyan,3 Ann C Childress,4 Frank A Lopez,5 Jonathan Rubin6 1Department of Clinical Research, Supernus Pharmaceuticals, Inc., Rockville, MD, USA; 2Department of Biostatistics, Supernus Pharmaceuticals, Inc., Rockville, MD, USA; 3D...
Guardado en:
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | article |
| Lenguaje: | EN |
| Publicado: |
Dove Medical Press
2021
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/812d44ea523f45a3826568c89782970b |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Sea el primero en dejar un comentario!